These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15136472)

  • 21. Dietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesis.
    Walaszek Z; Hanausek-Walaszek M; Webb TE
    Cancer Lett; 1986 Oct; 33(1):25-32. PubMed ID: 3768860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of lung cancer.
    Hong WK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):135-41. PubMed ID: 10550838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprevention of lung cancer: the rise and demise of beta-carotene.
    Omenn GS
    Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The problem of second cancers and the European experience with chemoprevention.
    Pastorino U
    Lung Cancer; 1994 Nov; 11 Suppl 3():S67-70. PubMed ID: 7704515
    [No Abstract]   [Full Text] [Related]  

  • 25. Hamster lung cancer model of carcinogenesis and chemoprevention.
    Moon RC; Rao KV; Detrisac CJ; Kelloff GJ
    Adv Exp Med Biol; 1992; 320():55-61. PubMed ID: 1442284
    [No Abstract]   [Full Text] [Related]  

  • 26. Dietary prevention of carcinogenesis in smokers.
    Caine GJ; Lip GY
    J Intern Med; 2002 Dec; 252(6):577-8. PubMed ID: 12472922
    [No Abstract]   [Full Text] [Related]  

  • 27. Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition).
    Gray J; Mao JT; Szabo E; Kelley M; Kurie J; Bepler G;
    Chest; 2007 Sep; 132(3 Suppl):56S-68S. PubMed ID: 17873160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer: chemoprevention and intermediate effect markers.
    Tockman MS
    IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cryptoxanthin and lung cancer in Shanghai, China--an examination of potential confounding with cigarette smoking using urinary cotinine as a biomarker for true tobacco exposure.
    Stram DO; Yuan JM; Chan KK; Gao YT; Ross RK; Yu MC
    Nutr Cancer; 2007; 57(2):123-9. PubMed ID: 17571944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
    Omenn GS
    Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of lung cancer. The new millennium.
    Kim ES; Hong WK; Khuri FR
    Chest Surg Clin N Am; 2000 Nov; 10(4):663-90, v. PubMed ID: 11091919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors].
    Bespalov VG; Aleksandrov VA
    Vopr Onkol; 2012; 58(4):537-40. PubMed ID: 23607211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early lung cancer as a potential target for chemoprevention.
    Melamed MR; Flehinger BJ
    J Cell Biochem Suppl; 1993; 17F():57-65. PubMed ID: 8412209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprevention of premalignant lesions of the upper aerodigestive tract. Workshop, February 10-14, 1993, Amelia Island, Florida. Proceedings.
    J Cell Biochem Suppl; 1993; 17F():1-300. PubMed ID: 8412182
    [No Abstract]   [Full Text] [Related]  

  • 36. Smokers and urinary genotoxins: implications for selection of cohorts and modulation of endpoints in chemoprevention trials.
    De Flora S; Camoirano A; Bagnasco M; Bennicelli C; van Zandwijk N; Wigbout G; Qian GS; Zhu YR; Kensler TW
    J Cell Biochem Suppl; 1996; 25():92-8. PubMed ID: 9027604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods and strategies in lung cancer control.
    Castonguay A
    Cancer Res; 1992 May; 52(9 Suppl):2641s-2651s. PubMed ID: 1562994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention strategies for lung and upper aerodigestive tract cancer.
    Benner SE; Lippman SM; Hong WK
    Cancer Res; 1992 May; 52(9 Suppl):2758s-2763s. PubMed ID: 1563008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapies for the prevention of lung cancer.
    Schachter EN; Neuman T
    Drugs Today (Barc); 2007 Dec; 43(12):897-936. PubMed ID: 18174975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors.
    Kowalczyk MC; Spears E; Narog M; Zoltaszek R; Kowalczyk P; Hanausek M; Yoshimi N; Slaga TJ; Walaszek Z
    Oncol Rep; 2011 Sep; 26(3):551-6. PubMed ID: 21687956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.